JNJ vs MRK
By Alex · Tickerpine
Johnson & Johnson vs Merck & Co., Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | MRK |
|---|---|---|
| Price | $263.81 | $145.27 |
| Market cap | $635.07B | $358.41B |
| P/E ratio | 40.0 | 117.2 |
| ROE | 20.02% | 6.96% |
| Profit margin | 16.20% | 4.77% |
| Revenue growth | 5.90% | 5.10% |
| Dividend yield | 2.03% | 2.34% |
| Beta | 0.21 | 0.22 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs MRK in plain English
- JNJ is the bigger company — about 1.8× the market cap of MRK.
- JNJ is cheaper on earnings (P/E 40.0 vs 117.2).
- JNJ earns a higher return on equity (20% vs 7%).
- JNJ is growing revenue faster (6% vs 5%).
- MRK has the higher dividend yield (2.34% vs 2.03%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.